Fermenta Biotech standalone net profit declines 6.20% in the March 2022 quarter
Sales rise 4.14% to Rs 94.66 crore
Net profit of Fermenta Biotech declined 6.20% to Rs 9.07 crore in the quarter ended March 2022 as against Rs 9.67 crore during the previous quarter ended March 2021. Sales rose 4.14% to Rs 94.66 crore in the quarter ended March 2022 as against Rs 90.90 crore during the previous quarter ended March 2021.For the full year,net profit declined 41.81% to Rs 30.24 crore in the year ended March 2022 as against Rs 51.97 crore during the previous year ended March 2021. Sales rose 4.06% to Rs 387.96 crore in the year ended March 2022 as against Rs 372.82 crore during the previous year ended March 2021.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content